美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
ZERIT	020412	001	NDA	STAVUDINE	CAPSULE;ORAL	5MG	No	No	1994/06/24	1994/06/24	BRISTOL	Discontinued
ZERIT	020412	002	NDA	STAVUDINE	CAPSULE;ORAL	15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/06/24	1994/06/24	BRISTOL	Discontinued
ZERIT	020412	003	NDA	STAVUDINE	CAPSULE;ORAL	20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/06/24	1994/06/24	BRISTOL	Discontinued
ZERIT	020412	004	NDA	STAVUDINE	CAPSULE;ORAL	30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/06/24	1994/06/24	BRISTOL	Discontinued
ZERIT	020412	005	NDA	STAVUDINE	CAPSULE;ORAL	40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1994/06/24	1994/06/24	BRISTOL	Discontinued
ZERIT	020413	001	NDA	STAVUDINE	FOR SOLUTION;ORAL	1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1996/09/06	1996/09/06	BRISTOL	Discontinued
ZERIT XR	021453	001	NDA	STAVUDINE	CAPSULE, EXTENDED RELEASE;ORAL	37.5MG	No	No	2002/12/31	2002/12/31	BRISTOL MYERS SQUIBB	Discontinued
ZERIT XR	021453	002	NDA	STAVUDINE	CAPSULE, EXTENDED RELEASE;ORAL	50MG	No	No	2002/12/31	2002/12/31	BRISTOL MYERS SQUIBB	Discontinued
ZERIT XR	021453	003	NDA	STAVUDINE	CAPSULE, EXTENDED RELEASE;ORAL	75MG	No	No	2002/12/31	2002/12/31	BRISTOL MYERS SQUIBB	Discontinued
ZERIT XR	021453	004	NDA	STAVUDINE	CAPSULE, EXTENDED RELEASE;ORAL	100MG	No	No	2002/12/31	2002/12/31	BRISTOL MYERS SQUIBB	Discontinued